This is a Trial of MG1-E6E7 With Ad-E6E7 and Atezolizumab in Patients With HPV Associated Cancers
Clinical trial NCT03618953 · TERMINATED
Trial details
- NCT number
- NCT03618953
- Sponsor
- Turnstone Biologics, Corp.
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2018-06-21
- Primary completion
- 2021-03-05
- Enrollment
- 8
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.